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Background: Herpes zoster (HZ) is caused by the re-activation
f latent varicella-zoster virus and is characterized by unilateral,
esicular cutaneous eruptions. Acute neuritis and post-herpetic
euralgia (PHN) are frequently debilitating, resulting in reduced
uality of life (QoL). This study assesses the burden of illness asso-
iated with HZ in Taiwan in a real-life clinical setting.
Methods: This was a prospective, observational, single-cohort
tudy. Patients were enrolled at various time points during the
ourse of a zoster episode and were followed for ≤6 months. HZ-
ssociated pain (ZAP) was assessed with the Initial Zoster Impact
uestionnaireand theZosterBrief Pain Inventory.QoLwasassessed
ith the EQ-5D instrument using the Japan preference weights.
Results: The cohort comprised 150 HZ patients with a mean
SD) age of 64.9 (9.2) years and equal gender distribution. At base-
ine, mean (SD) time since rash onset was 18.8 (78.3) days. At the
rodrome phase, a signiﬁcant proportion (63.9%) of patients expe-
ienced a worst pain score of ≥5. ZAP was reported by 147 (98%)
atients at baseline.Mean (SD)worst pain score decreased from6.0
3.1) at baseline to 2.7 (3.0) at 30 days and 0.3 (0.8) at 180 days. PHN
worst pain ≥3 after ≥90 days since rash onset) was experienced
y 28 (18.7%) patients. The mean (SD) EQ-5D score signiﬁcantly
ecreased (P<0.001) from 0.91 (0.16) before rash onset to 0.67
0.18) after rash onset, increasing thereafter, showing signiﬁcant
P<0.05)QoLdeteriorationup to60dayspost-rashonset.Acutepain
everity (worst pain) and days of pain at rash onset were signiﬁ-
antpredictors (P<0.001) of poorerQoLat follow-upuponadjusting
or QoL before rash onset. Furthermore, acute pain severity and
uration interfered signiﬁcantly (P<0.05) with all EQ-5D health
omains–mobility, self-care, usual activities, pain/discomfort, anx-
ety/depression.
Conclusion: HZ pain can signiﬁcantly reduce QoL and ability
o perform daily activities of people living in Taiwan. Severity and
uration of acute pain at rash onset were identiﬁed as robust pre-
ictors of poor patient QoL. These ﬁndings are consistent with
bservational studies in other countries.
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Xenobiotical virology: novel mechanistic concept of hazardous
human viruses upregulation by body burden level of dioxins via
AhR-mediated transcriptional pathway
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Background: Earlier we discovered transactivation of the HIV-
1 and hepatitis B virus (HBV) in human cells by 30-300 ppt
dioxin, a xenobioticwith extremely long serumhalf-life in humans.
Also, upregulation of cytomegalovirus (HCMV) in human cells was
shown by 10 ppq dioxin whereas current its background level in
general population is ∼4 ppt. So, human viruses were suggested
novel target genes of cellular dioxin receptor (AhR/Arnt) complex.
The complex was known as binding to dioxin-responsive elements
(DRE) within mammalian genes, and amount of DREs determine
level of target gene activation.
Methods: Productions of infectious HIV-1 in MT4 cells, HCMV
in THP-1 cells, and HBV in HepG2 cells were determined using
plaque assay. ViralDNAswere determined by hybridization and PCR.
A computational search for viral DRE was performed by SITECON, a
tool for detecting transcription factor binding site alignments/site
recognition.
Results: A total of 13 bona ﬁde DRE, all including the substitu-
tion intolerant core sequence (5’-GCGTG-3’) and SITECON-selected
adjacent variable sequences were used here to detect the above
properties for the DRE site, and conformational similarity score
threshold of 0.95 was utilized to rank identiﬁed DRE. It was found
that regulatory region of HCMV genes encoding IE gp/UL37 has
5 DRE, 1.65 kb/UL36 – 6 DRE, pp65 – 7 DRE, pp71 – 7 DRE, and
pp150 –10 DRE. Wile juxtaposing DRE contents with experimental
results, the most susceptible candidate virus to be augmented with
body burden dioxin is that one possessing at least similar to HCMV
amount of DRE. SITECON recognized several cancer-associated
human viruses possessing multiple DREs in their promoters. Thus
Epstein-Barr virus (EBV) promoters L1A and L1 each contain 16
DRE, and gene of EBV R1 145K - 11 DRE. Genes encoding some
major proteins of herpes simplex virus (HSV) type 1 have from 7 to
8 promoter DRE.
Conclusion: The above support the concept, and provide evi-
dence that sub-nanomolar dioxin is able to activateDRE-containing
viruses. Mechanistic data obtained allow searching for inhibitors
of viremia and virally-driven malignancies among antagonist lig-
ands of cytosolic Ah receptor, and modiﬁers of AhR/Arnt complex
binding to viral DRE.
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